Results 71 to 80 of about 248 (96)

A strategy to re-sensitise drug-resistant Gram-positive bacteria to oxazolidinone-class antibiotics. [PDF]

EBioMedicine
Zhang Q, Yang Y, Yang Y, Shang J, Su S, Gao P, Li XX, Liu Z, Kao RY, Ko BC, Thompson B, Zhao Q.   +11 more
europepmc   +1 more source

Neuromyelitis optica causing vision loss during TB treatment with sutezolid: evidence of aberrant immunity following infection. [PDF]

IJTLD Open
Glover NA, Paramo L, Giangregorio S, Sukwana B, Koele SE, Charalambous S, Ngwanto T, Mashatole S, Mudzengi D, Heinrich N, Svensson EM, Abdullah F, Churchyard G, Wallis RS.   +13 more
europepmc   +1 more source

Tuberculosis parenteral therapeutic regimens for critical patients or non-functional intestinal tract: Brief review and proposal of protocol. [PDF]

Braz J Infect Dis
Martins AC, Garcia MT, Resende MR.
europepmc   +1 more source

Recent Progress and Challenges for Drug-Resistant Tuberculosis Treatment. [PDF]

Pharmaceutics, 2021
Stephanie F, Saragih M, Tambunan USF.
europepmc   +1 more source

Drug-Resistant Tuberculous Meningitis (DR-TBM) in a Low-Incidence Setting: Two Cases and an Evidence Review Highlighting Key Advances and Knowledge Gaps in Clinical Management. [PDF]

Open Forum Infect Dis
Boschung KF, Wong PHP, Werry D, Sekirov I, Turvey SL, Cook VJ, Johnston J, Connors WJA.   +7 more
europepmc   +1 more source

<i>tert</i>-Butyl Carbonate as a Nucleophile in Epoxide Ring Opening: A Cascade Synthesis of 5-(Hydroxymethyl)oxazolidin-2-one. [PDF]

J Org Chem
Lee K, Lee X, Zhou CY, Chu YL, Lin CK.
europepmc   +1 more source

Epidemiologie, Diagnostik und Therapie von Tuberkulose und anderen Infektionskrankheiten in Sub-Sahara Afrika [PDF]

, 2022
Heinrich, Norbert
core   +3 more sources

Activity of combinations of bactericidal and bacteriostatic compounds in <i>Mycobacterium abscessus</i>-infected mice: an overview. [PDF]

Front Microbiol
Lanni A, Iona E, Fattorini L, Giannoni F, Iacobino A.   +4 more
europepmc   +1 more source

The Structure, Properties, and Clinical Utility of Contezolid for Antituberculosis: A Narrative Review. [PDF]

Infect Dis Ther
Chen T, Li W, Shen F, Nie W, Wu F.
europepmc   +1 more source

Revolutionizing tuberculosis treatment: Breakthroughs, challenges, and hope on the horizon. [PDF]

Acta Pharm Sin B
Kufa M, Finger V, Kovar O, Soukup O, Torruellas C, Roh J, Korabecny J.   +6 more
europepmc   +1 more source